Human cells contain ribosomes, a complex machine that produces proteins for the rest of the body. Now the researchers have come closer to understanding how the ribosome works.
"It is amazing that we can visualize the atomic details of the ribosome. Because they are tiny – around 20-30 nanometers."
So says Associate Professor Eva Kummer from the Novo Nordisk Foundation Center for Protein Research, who is responsible for the new study published in Nature Communications.
And don't worry if you don't know how much a nanometer is. It is around one billionth of a meter.
The Ribosome
The ribosome is a part of the human cell consisting of ribosomal RNA and ribosomal proteins.
The ribosome is like a factory that builds proteins by following a set of instructions inherent in the genes.
Ribosomes are found floating in the cell cytosol, cellular organelles such as mitochondria or the protoplasm of bacteria.
Using electron microscopy, Eva Kummer and her colleagues Giang Nguyen and Christina Ritter have managed to produce a 3D model of a part of the human cell, the ribosome, which is no more than 30 nanometers in diameter.
More specifically, they have taken snapshots of how a ribosome is made.
"It is important to understand how the ribosome is built and how it works, because it is the only cell particle that produces proteins in humans and all other living organisms. And without proteins, life would cease to exist," says Eva Kummer.
Proteins are the primary building blocks of the human body. Your heart, lungs, brain, and basically your whole body is made of proteins produced by the ribosome.
"From the outside, the human body looks pretty simple, but then consider the fact that every part of the body consists of millions of molecules, that are extremely complex, and that they all know what to do – that is pretty breathtaking," says Eva Kummer.
The complex assembling process of the ribosome. Credit: Eva Kummer
Folding, Assembling, and Moving to the Right Place
Before ribosomes can start to produce proteins, they first need to be assembled from over 80 different components.
Eva Kummer and her colleagues have obtained 3D models of three different stages of ribosome assembly.
"It is a complex particle with lots of different parts – many proteins and RNA components – that must be folded, assembled, and moved to the right place. It does not all happen at once. Ribosome assembly is a gradual process involving several stages," she explains.
Out of the three stages, the 3D model describing the earliest time point in the assembly is the most interesting, according to Eva Kummer, as no one has been able to describe it before.
"At this stage, we can tell e.g. that a specific protein called GTPBP10 is eager to interact with a so-called RNA component that forms a long helix," Eva Kummer says and adds:
"In fact, towards the bottom of that helix is the catalytic center of the ribosome, which is where proteins are made. This is why it is so important that the helix is folded and placed correctly. "
To achieve this, GTPBP10 grabs the helix and puts it in the right position for protein synthesis.
This is just one of the many stages of ribosome assembly which the new study has shed light on – insight that may pave the way for more knowledge of various diseases.
"Errors in ribosome assembly severely reduce the capacity of our cells to make proteins. These are for example proteins that convert the energy from the food we eat into energy coins that the body can use to run all sorts of cellular processes. Now, if the mitochondrial ribosome does not work, our body cannot produce enough energy coins anymore and this leads to diseases such as neurodegenerative disorders and heart conditions. And during aging, the production of these energy coins also works less and less efficiently," Eva Kummer says and adds:
"The first step is understanding how things work. Only then can you try to change them."
You can read "Structural insights into the role of GTPBP10 in the RNA maturation of the mitoribosome" in Nature Communications.
Reference: "Structural insights into the role of GTPBP10 in the RNA maturation of the mitoribosome" by Thu Giang Nguyen, Christina Ritter and Eva Kummer, 2 December 2023, Nature Communications.
DOI: 10.1038/s41467-023-43599-z
News
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]















